Rathbones Group Portfolio holdings
Rathbones Group is a British wealth manager that looks after investments for private investors and trustees, and it traces its roots to a timber trading business founded by William Rathbone II by 1742. Its services include investment management, unit trusts, tax planning, trust management, pension advice and banking. The business, then a partnership, took the name Rathbone Bros in 1824 and, from the late nineteenth century, shifted away from overseas trading and shipping toward investment services. It dropped the name Rathbone Brothers for Rathbones Group in 2021, and in 2023 it agreed to buy the UK and Channel Islands wealth businesses of Investec, a deal that combined the two firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RingCentral
RNG
|
+$27.5M |
| 2 |
Boston Scientific
BSX
|
+$25.3M |
| 3 |
Lamb Weston
LW
|
+$6.07M |
| 4 |
Autodesk
ADSK
|
+$5.95M |
| 5 |
FirstCash
FCFS
|
+$5.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$34.4M |
| 2 |
Booking.com
BKNG
|
+$22.2M |
| 3 |
WEC Energy
WEC
|
+$7.17M |
| 4 |
Morgan Stanley
MS
|
+$4.67M |
| 5 |
Intel
INTC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.19% |
| 2 | Technology | 20.97% |
| 3 | Consumer Staples | 11.16% |
| 4 | Healthcare | 11.16% |
| 5 | Communication Services | 9.42% |
Similar funds
Rathbones Group's Q2 2019 Portfolio in Review
As of Q2 2019, Rathbones Group held 324 positions worth $3.19B, up 5% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Rathbones Group's Q2 2019 filing shows 11 new, 97 increased, 113 reduced and 9 closed positions. Its largest new stake was RingCentral: 238,300 shares worth $27.4M. The largest sale was Abiomed Inc, an estimated $34.4M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Rathbones Group's largest Q2 2019 buy was RingCentral: 238,300 shares worth $27.4M.
- Rathbones Group added most to Boston Scientific in Q2 2019, an estimated $25.3M increase.
- Rathbones Group's biggest Q2 2019 reduction was Abiomed Inc, cutting an estimated $34.4M.
- Rathbones Group fully exited Goldcorp Inc in Q2 2019, selling an estimated $461K.
- Rathbones Group's ten largest holdings make up 30% of its $3.19B portfolio in Q2 2019.
- Rathbones Group opened 11 new positions and closed 9 in Q2 2019.
- Rathbones Group's portfolio value rose 5% quarter-over-quarter to $3.19B.
Based on Rathbones Group's 13F filing for Q2 2019, filed 12 Aug 2019.